EurekAlert! -
21 Apr 2014 06:00
(Dana-Farber Cancer Institute) Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the US Food and Drug Administration approved first targeted drug as treatment for advanced stomach cancer.
Share this Article